IGF2BP1 and cancer: For example, one study in hepatocellular carcinoma found that IGF2BP1 was able to combine with LIN28B-AS1 to promote the stability and translation of MYC mRNA in an m6A-modification-dependent manner, boosting the proliferation and invasion of cancer cells (24–26).